ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ORN vs TMO // 10Y YIELD & FRED MACRO BETA

Orion Group Holdings Inc. Common (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ORN 2 — TMO 10
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORN VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ORN TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 12.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 7.10% 9.30% -2.20 TMO /roic <GO>
EV/EBITDA & P/E Valuation 7.9x 30.4x -22.50 ORN /valuation <GO>
Free Cash Flow Yield -2.91% 2.40% -5.31 TMO /fcf-yield <GO>
Operating Margin 1.70% 17.40% -15.70 TMO /operating-margins <GO>
Net Profit Margin 0.30% 15.10% -14.80 TMO /net-margins <GO>
Revenue Growth (YoY) 7.00% 3.90% +3.10 ORN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.05 4.50 -1.45 TMO /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.4 62.9 -18.49 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 138.5x 36.3x +102.20 TMO /forward-pe <GO>
Enterprise Scale & Market Cap $370.4M $262.22B -$261.85B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ORN REV TMO REV ORN GROSS % TMO GROSS % ORN FCF TMO FCF
FY 2025 $852.3M $44.56B 12.4% — -$10.8M $6.29B
FY 2024 $796.4M $42.88B 11.4% — -$1.4M $7.27B
FY 2023 $711.8M $42.86B — — $17.2M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORN // BETA —
TMO // BETA 0.94